Phenylbutazone in treatment of acute lumbago-sciatica.
In a double-bind investigation of the effect phenylbutazone (initially injected + Butazolidin Alka p.o.) was compared with that of placebo in 36 patients with acute lumbago-sciatica without root involvement in the form of paresis. The investigation showed that the effect of phenylbutazone was significantly better than that of placebo. The side-effects of the drug were mild.
D000208:Acute Disease; D000328:Adult; D001416:Back Pain / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000627:therapeutic use*; D010919:Placebos; D012585:Sciatica / Q000188:drug therapy*
D010919:Placebos; D010653:Phenylbutazone